We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease. At Glyphic Biotechnologies, we are creating…
Location: United States, California, San Francisco
Total raised: $6M
Founders name: Joshua Yang
Investors 6
Date | Name | Website |
- | BioTools I... | biotoolsin... |
- | Civilizati... | civilizati... |
- | OMX Ventur... | omx.vc |
22.07.2021 | Cantos Ven... | cantos.vc |
- | Axial VC | axialvc.co... |
- | StartX | startx.com |
Funding Rounds 1
Date | Series | Amount | Investors |
26.07.2021 | - | $6M | - |
Persons 1
Date | First Name | Last Name | Title | |||
- | Joshua | Yang | Co-Founder... | linkedin.c... | - | - |
Mentions in press and media 2
Date | Title | Description | Source |
14.06.2023 | Glyphic AI Raises $5.5m to Build AI Copilot For Sales teams | Glyphic AI announced today that it raised $5.5m to build an AI copilot that assists sales teams in a... | martechcub... |
26.07.2021 | Glyphic Biotechnologies raises $6M to accelerate protein seq... | The whole human proteome may be free to browse thanks to DeepMind, but at the bleeding edge of biote... | techcrunch... |